谷歌浏览器插件
订阅小程序
在清言上使用

A single dose of SARS CoV 2 FINLAY FR 1A dimeric RBD recombinant vaccine enhances neutralization response in COVID19 convalescents, with excellent safety profile. A preliminary report of an open-label phase 1 clinical trial

medRxiv(2021)

引用 6|浏览17
暂无评分
关键词
recombinant vaccine,single dose,neutralization response,sars-cov,dimeric-rbd,open-label
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要